Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Glioma × Radiotherapy × Clear all

Phase

Status

Completed 30 Recruiting 8 Unknown 7 Active not recruiting 6 Terminated 4 Withdrawn 1 Not yet recruiting 1 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 5 Rectal Neoplasms 5 Glioblastoma 4 Carcinoma, Non-Small-Cell Lung 4 Uterine Cervical Neoplasms 3 Small Cell Lung Carcinoma 3 Prostatic Neoplasms 3 Non-Muscle Invasive Bladder Neoplasms 3 Neoplasms 3 Nasopharyngeal Carcinoma 3 Esophageal Neoplasms 3 Brain Neoplasms 3 Urinary Bladder Neoplasms 2 Triple Negative Breast Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Colorectal Neoplasms 2 Carcinoma 2 Stomach Neoplasms 1 Small Cell Lung Cancer Extensive Stage 1 Sarcoma 1 Rhabdomyosarcoma 1 Rectal Cancer Patients 1 Radiotherapy-induced Oral Mucositis 1 Radiation Injuries 1 Pelvic Neoplasms 1 Oropharyngeal Neoplasms 1 Neoplasm Metastasis 1 NSCLC 1 Muscle-invasive Bladder Cancer 1

Interventions

Temozolomide 3 vorasidenib 1 trametinib 1 tovorafenib 1 posaconazole 1 perillyl alcohol 1 pembrolizumab 1 niraparib 1 gallium maltolate 1 dabrafenib 1 contrast agent BR1 1 Standard of Care 1 Radiotherapy 1 Positron Emission Tomography Computed Tomography 1 Physical Therapy Modalities 1 Nivolumab 1 Microscopy 1 Mental Status and Dementia Tests 1 Lomustine 1 Ketoconazole 1 Histocompatibility Testing 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Electrocorticography 1 Electric Stimulation 1 Cyclophosphamide 1 Craniotomy 1 Blood Specimen Collection 1 Biopsy 1 Bevacizumab 1 Aminolevulinic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07457307 2026-03-09

INSIGHT MRL

NYU Langone Health

Phase 1 Not yet recruiting

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡